Yahoo Web Search

  1. Ad
    related to ELI LILLY AND COMPANY
  1. Hedge Funds Are Selling Royal Bank of Canada (RY)

    Insider Monkey via Yahoo FinanceOct 10 13:55 PM

    A pair of the less known formulas are hedge fund and insider trading activity.

  2. The phase III study is part of the phase III program, which includes two identical phase III studies to evaluate safety and efficacy of lebrikizumab as monotherapy in patients. The studies ...

  3. Is Amgen, Inc. (AMGN) A Good Stock To Buy According To Hedge Funds?

    Insider Monkey via Yahoo FinanceOct 09 20:46 PM

    The huge amount of capital does not allow hedge funds to invest a lot in small-caps, but our research showed that their most popular small-cap ideas are less efficiently priced and generate ...

  4. Our calculations also showed that UTX isn't among the 30 most popular stocks among hedge funds (see the video below). Video: Click the image to watch our video about the top 5 most popular hedge ...

  5. Karen Walker, a veteran of more than 20 years of global technology industry marketing, will join Intel as senior vice president and chief marketing officer (CMO), effective Oct. 23. Walker ...

  6. A few FDA approvals came through, with Puma Biotechnology Inc (NASDAQ: PBYI) getting a label expansion for its breast cancer drug Nerlynx and Novartis AG (NYSE: NVS)'s Entresto, a combo ...

  7. Mairs and Power Growth Fund Comments on Elanco Animal Health

    GuruFocus.com via Yahoo FinanceSep 27 22:50 PM

    Health (NYSE:ELAN), recently appeared in the Fund as the result of its spin-off from Eli Lilly and Co (NYSE:LLY). It holds a strong market position with a diverse product ...

  8. Verastem's (VSTM) Copiktra Gets Orphan Drug Designation

    Zacks via Yahoo FinanceOct 08 14:02 PM

    Verastem, Inc. VSTM announced that the FDA has granted orphan drug designation to Copiktra (duvelisib) for the treatment of T-Cell lymphoma. The drug already enjoys Fast Track designation for this indication.

  9. FDA approves Pfenex's osteoporosis therapy

    Reuters via Yahoo FinanceOct 07 10:00 AM

    Food and Drug Administration on Monday approved a bone-building drug... to treat osteoporosis in certain patients at high risk for fractures, giving the company its first commercial ...

  10. The FINCH phase III program evaluated the efficacy and safety of 100 mg and 200 mg filgotinib once daily in early-stage to biologic-experienced RA patients. FINCH 1 was a 52 week ...

  1. Ads
    related to ELI LILLY AND COMPANY